ARCHIVES

FDA: Oncology Division Director Delap Promoted In Agency

This article is from The Cancer Letter archive.

Vol. 24 No. 21 | May 29, 1998

Download PDF Visit The Full Archive

Related Articles

NCI’s Weinstein Said He Never Pressured Researcher

November 3, 1995

ODAC Votes For Accelerated Approval For Adcetris For Two Lymphoma Indications

July 22, 2011

BMS Settles Charges Of Obstructing Generics

March 14, 2003

FDA Oncologic Drugs Advisory Committee Okays THC For Group C List

July 4, 1980

DCCR Gets Go Ahead For New Community Clinical Oncology Program, $600,000 – $1 Million a Year

May 12, 1978

Plan To Reprogram $10 Million On Construction Funds Draws Criticism

November 19, 1976